Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer by T J. Whelan, et al., for the LUMINA Study Investigators (August 17, 2023 N Engl J Med 2023; 389:612-619 DOI: 10.1056/NEJMoa2302344)

Serge Rozenberg

 

 

T J. Whelan, et al., for the LUMINA Study Investigators (August 17, 2023 N Engl J Med 2023; 389:612-619 DOI: 10.1056/NEJMoa2302344) performed a prospective cohort study involving women who were at least 55 years of age, had undergone breast-conserving surgery for T1N0 (tumor size <2 cm and node negative), grade 1 or 2, luminal A–subtype breast cancer (defined as estrogen receptor positivity of ≥1%, progesterone receptor positivity of >20%, negative human epidermal growth factor receptor 2, and Ki67 index of ≤13.25%), and had received adjuvant endocrine therapy. Patients who met the clinical eligibility criteria were registered, and Ki67 immunohistochemical analysis was performed centrally. Patients with a Ki67 index of 13.25% or less were enrolled and did not receive radiotherapy. The primary outcome was local recurrence in the ipsilateral breast. In consultation with radiation oncologists and patients with breast cancer, the authors determined that if the upper boundary of the two-sided 90% confidence interval for the cumulative incidence at 5 years was less than 5%, this would represent an acceptable risk of local recurrence at 5 years.

Of 740 registered patients, 500 eligible patients were enrolled. At 5 years after enrollment, recurrence was reported in 2.3% of the patients (90% CI, 1.3 to 3.8; 95% CI, 1.2 to 4.1), a result that met the pre-specified boundary. Breast cancer occurred in the contralateral breast in 1.9% of the patients (90% CI, 1.1 to 3.2), and recurrence of any type was observed in 2.7% (90% CI, 1.6 to 4.1).

CONCLUSIONS

Among women who were at least 55 years of age and had T1N0, grade 1 or 2, luminal A breast cancer that were treated with breast-conserving surgery and endocrine therapy alone, the incidence of local recurrence at 5 years was low with the omission of radiotherapy.

No data was found

Latest news

01/06/2024
Our next BMS meeting Saturday June 1st, 2024 : Topic : Hormonal and non-hormonal treatments of menopause